Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Thorne HealthTech Inc.

    NASDAQ: THRN · Real-Time Price · USD
    10.19
    -0.01 (-0.10%)
    At close: Oct 13, 2023, 10:00 PM

    Thorne HealthTech Statistics

    Share Statistics

    Thorne HealthTech has 54.04M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 54.04M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 15.73M

    Failed to Deliver (FTD) Shares

    n/a
    		 28,555

    FTD / Avg. Volume

    n/a
    		 11.66%

    Short Selling Information

    The latest short interest is 267.44K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 267.44K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 2.19%

    Short Ratio (days to cover)

    n/a
    		 2.64

    Valuation Ratios

    The PE ratio is 12.22 and the forward PE ratio is null. Thorne HealthTech's PEG ratio is -1.34.

    PE Ratio

    n/a
    		 12.22

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.84

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.32

    P/FCF Ratio

    n/a
    		 -15.15

    PEG Ratio

    n/a
    		 -1.34
    Financial Ratio History

    Enterprise Valuation

    Thorne HealthTech has an Enterprise Value (EV) of 202.52M.

    EV / Sales

    n/a
    		 0.89

    EV / EBITDA

    n/a
    		 19.65

    EV / EBIT

    n/a
    		 38.78

    EV / FCF

    n/a
    		 -16.02

    Financial Position

    The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.32.

    Current Ratio

    n/a
    		 2.95

    Quick Ratio

    n/a
    		 1.47

    Debt / Equity

    n/a
    		 0.32

    Debt / EBITDA

    n/a
    		 4.56

    Debt / FCF

    n/a
    		 -3.72

    Interest Coverage

    n/a
    		 208.19

    Financial Efficiency

    Return on Equity is 10.81% and Return on Invested Capital is 5.45%.

    Return on Equity

    n/a
    		 10.81%

    Return on Assets

    n/a
    		 6.82%

    Return on Invested Capital

    n/a
    		 5.45%

    Revenue Per Employee

    n/a
    		 $420,462.06

    Profits Per Employee

    n/a
    		 $28,812.57

    Employee Count

    n/a
    		 544

    Asset Turnover

    n/a
    		 1

    Inventory Turnover

    n/a
    		 1.94

    Taxes

    Income Tax

    n/a
    		 -7.31M

    Effective Tax Rate

    n/a
    		 -93.75%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0.82, so Thorne HealthTech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.82

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 9.24

    200-Day Moving Average

    n/a
    		 5.78

    Relative Strength Index (RSI)

    n/a
    		 72.14

    Average Volume (20 Days)

    n/a
    		 244,810

    Income Statement

    In the last 12 months, Thorne HealthTech had revenue of 228.73M and earned 15.67M in profits. Earnings per share was 0.3.

    Revenue

    n/a
    		 228.73M

    Gross Profit

    n/a
    		 114.93M

    Operating Income

    n/a
    		 5.48M

    Net Income

    n/a
    		 15.67M

    EBITDA

    n/a
    		 10.31M

    EBIT

    n/a
    		 7.82M

    Earnings Per Share (EPS)

    n/a
    		 0.3
    Full Income Statement

    Balance Sheet

    The company has 36.02M in cash and 47.03M in debt, giving a net cash position of -11.01M.

    Cash & Cash Equivalents

    n/a
    		 36.02M

    Total Debt

    n/a
    		 47.03M

    Net Cash

    n/a
    		 -11.01M

    Retained Earnings

    n/a
    		 -116.48M

    Total Assets

    n/a
    		 282.53M

    Working Capital

    n/a
    		 79.22M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 5.22M and capital expenditures -17.86M, giving a free cash flow of -12.64M.

    Operating Cash Flow

    n/a
    		 5.22M

    Capital Expenditures

    n/a
    		 -17.86M

    Free Cash Flow

    n/a
    		 -12.64M

    FCF Per Share

    n/a
    		 -0.24
    Full Cash Flow Statement

    Margins

    Gross margin is 50.25%, with operating and profit margins of 2.4% and 6.85%.

    Gross Margin

    n/a
    		 50.25%

    Operating Margin

    n/a
    		 2.4%

    Pretax Margin

    n/a
    		 3.41%

    Profit Margin

    n/a
    		 6.85%

    EBITDA Margin

    n/a
    		 4.51%

    EBIT Margin

    n/a
    		 2.4%

    FCF Margin

    n/a
    		 -5.53%

    Dividends & Yields

    THRN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 8.18%

    FCF Yield

    n/a
    		 -6.6%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for THRN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 4.29

    Graham Upside

    n/a
    		 -57.9%

    Scores

    Altman Z-Score

    n/a
    		 3.44

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist